-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Nintedanib is a drug that is primarily used to treat lung cancer and other forms of cancer.
The production process of nintedanib involves several steps, each of which must be carried out with great precision and care to ensure that the final product is safe and effective.
The first step in the production process of nintedanib is the synthesis of the starting material.
The starting material for nintedanib is a compound called (S)-4-((2R)-2-oxo-1,3-oxazolidin-3-yl)-2-(difluoromethyl)pyrimidine-5-carbonitrile, which is synthesized through a multi-step process that involves the addition of different reagents and protecting groups to the starting material.
Once the starting material has been synthesized, it is purified through a series of chromatography techniques, such as high-performance liquid chromatography (HPLC) and flash chromatography.
This purification step is important to remove any impurities that may have been introduced during the synthesis process, and to ensure that the starting material is of the highest possible purity.
Next, the purified starting material is treated with a series of reagents to convert it into the desired product.
This process typically involves the use of reagents such as acids, bases, and different types of reagents that are used to protect the various functional groups present in the starting material.
After the conversion step, the product is purified through a series of chromatography techniques, such as HPLC and flash chromatography, to remove any impurities that may have been introduced during the conversion process.
The purified product is then dried and milled to achieve a fine powder, which is then ready for use in the final product.
Throughout the production process of nintedanib, various tests are carried out to ensure that the final product meets all the required specifications.
These tests include chemical tests to determine the purity of the product, and physiochemical tests to determine the stability and solubility of the product.
In addition to the production process outlined above, the production of nintedanib also involves the use of various analytical techniques to ensure the quality of the final product.
These techniques include spectroscopic methods, such as UV-Vis and IR spectroscopy, and mass spectrometry, which are used to identify and quantify the various components present in the final product.
Overall, the production process of nintedanib is a complex and multi-step process that requires a high degree of precision and accuracy.
Each step of the process must be carried out with the utmost care to ensure that the final product is safe and effective for use in treating cancer.
With ongoing research and development, it is likely that the production process of nintedanib will continue to improve and evolve in the future.